PONTEFINA
Live / Registered — Registered (as of 21 May 2024)
What this means for you
Registered since 21 May 2024. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 21 May 2030: the §8 declaration of use).
Record
- Serial number
- 97654034
- Registration number
- 7393056
- Mark type
- Word mark
- Filed
- 29 Oct 2022
- Published for opposition
- 26 Sept 2023
- Registered
- 21 May 2024
- Next maintenance filing
- §8 declaration of use, due by 21 May 2030 (grace period to 21 Nov 2030)
- Attorney of record
- RUBEN ALCOBA
Goods and services
- Class 005 — Pharmaceuticals: Medicaments for fungal, bacterial, viral infections, and other conditions and disorders, namely, athlete's foot, bedsores, burns, cold sores, fever blisters, dermatitis, diabetic ulcers, diaper rash, eczema, foot and leg ulcers, hemorrhoids, itch and rash, molluscum, poison ivy, oak and sumac, pressure sores, psoriasis, ringworm, rosacea, seborrheic dermatitis, shingles, skin infections, sunburn, tinea versicolor, warts, wounds, damaged skin and tissue
Owner
- PONTEFINA, INC., OAKLAND PARK, FL, US
- PONTEFINA, INC., OAKLAND PARK, FL, US
- PONTEFINA, INC., OAKLAND PARK, FL, US
Prosecution history
- 21 May 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 21 May 2024 — REGISTERED-PRINCIPAL REGISTER
- 16 Apr 2024 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 16 Apr 2024 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 03 Apr 2024 — STATEMENT OF USE PROCESSING COMPLETE
- 13 Mar 2024 — USE AMENDMENT FILED
- 03 Apr 2024 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 13 Mar 2024 — TEAS STATEMENT OF USE RECEIVED
- 21 Nov 2023 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 26 Sept 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 26 Sept 2023 — PUBLISHED FOR OPPOSITION
- 06 Sept 2023 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 19 Aug 2023 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 16 Aug 2023 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 16 Aug 2023 — CORRESPONDENCE RECEIVED IN LAW OFFICE